Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Shanghai Henlius Biotech, Inc. Proxy Solicitation & Information Statement 2015

Jun 3, 2015

50763_rns_2015-06-03_47884665-525a-44c8-98d5-de0f792d582a.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [85 x 53] intentionally omitted <==

比亞迪股份有限公司 BYD COMPANY LIMITED

(A joint stock company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 1211)

FORM OF PROXY FOR THE SECOND EXTRAORDINARY GENERAL MEETING IN 2015 TO BE HELD ON 21 JULY 2015 (OR ANY ADJOURNMENT THEREOF)

I/We (Note 1) of (Note 1) being the registered holders of (Note 2) H shares in BYD COMPANY LIMITED (the “ Company ”), HEREBY APPOINT (Note 3) the Chairman of the meeting, or of or failing him of as my/our proxy to attend and act for me/us at the Extraordinary General Meeting of the Company (or any adjournment thereof) to be held on Tuesday, 21 July 2015 at 9:00 a.m. at the Company’s Conference Room, No. 3009, BYD Road, Pingshan New District, Shenzhen, the People’s Republic of China and to vote at such meeting in respect of the resolutions as hereunder indicated, or if no such indication is given, as my/our proxy thinks fit.

By way of ordinary resolution By way of ordinary resolution By way of ordinary resolution For
(Note 4)
Against
(Note 4)
Abstain
(Note 4)
1. To consider and approve the resolution “the Company satisfies the conditions for non-public issuance of A
Shares”.
By way of special resolution
2. To consider and approve the proposal for the non-public issuance of A Shares by the Company.
2.01
Class of shares to be issued and nominal value
2.02
Method of issue
2.03
Target subscribers and method of subscription
2.04
Price determination date and basis of determination of issue price
2.05
Number of new A Shares to be issued
2.06
Lock-up period
2.07
Amount and use of proceeds
2.08
Arrangement relating to the distributable profits of the Company accumulated but not declared
2.09
Validity period of the resolutions in respect of
the Additional A Shares Issue
2.10
Place of listing
3. To consider and approve the plan for the non-public issuance of A Shares by the Company.
By way of ordinary resolution
4. To consider and approve the feasibility report on the use of proceeds raised from the non-public issuance of A
Shares by the Company.
By way of special resolution
5. To consider and approve the amendments to the Articles of Association.
6. To consider and approve the plan for dividend return to the Shareholders (2015-2017) by the Company.
7. To consider and approve the authorization to the Board or its authorized representative(s) at the Shareholders’
meeting to handle all matters relating to the non-public issuance of A Shares.
By way of ordinary resolution
8. To consider and approve the explanation on the use of proceeds of the previous fund raising.
9. To consider and approve the amendment of the management policy for funds raised.
By way of special resolution
10.
To consider and approve the amendment of the rules
and procedures of shareholders’ meeting.
  • Further details of the resolutions are set out in the notice of Extraordinary General Meeting dated on or around 4 June 2015.

Date Signature(s) (Note 5)

Notes:

  1. Please insert full name(s) and address(es) in block capitals.

  2. Please indicate clearly the number of H Shares in the Company registered in your name(s) in respect of which the proxy is so appointed. If no such number is inserted, the proxy will be deemed to be appointed in respect of all the H Shares in the Company registered in your name(s).

  3. Where the proxy appointed is not the Chairman of the meeting, please cross out “the Chairman of the meeting, or”, and fill in the name(s) and address(es) of the proxy in the space provided. Each shareholder is entitled to appoint one or more than one proxy to attend and vote at the meeting on his behalf. The proxy needs not be a member of the Company. The person who signs this proxy form shall initial against any alteration in it.

  4. Important: if you wish to vote for any resolution, tick in the box marked “For”. If you wish to vote against any resolution, tick in the box marked “Against”. If you wish to abstain from voting in respect of any resolution, tick in the box marked “Abstain”, and your voting will be counted in the total number of votes cast in that resolution for the purpose of calculating the result of that resolution. Failure to tick any box will entitle your proxy to cast your vote at his discretion.

  5. This form of proxy must be signed by you or your attorney duly authorized in writing (in this case, the power of attorney must be notarially certified) or, in the case of a corporation or institution, either under the corporate seal or under the hand of the chairman of its board of directors or attorney duly authorized in writing.

  6. To be valid, this proxy form and, if such proxy form is signed by a person under a power of attorney or other authority on behalf of the appointor, a notarially certified copy of that power of attorney or other authority (if applicable), must be deposited for the holders of H Shares of the Company at the following address of Computershare Hong Kong Investor Services Limited not less than 24 hours before the time appointed for the holding of the meeting. Computershare Hong Kong Investor Services Limited’s address is:

  7. 17M Floor, Hopewell Centre

  8. 183 Queen’s Road East

Wanchai

  • Hong Kong

  • Any alteration made to this proxy form must be initialled by the person(s) who sign it.